Andrew Obenshain - Mar 1, 2023 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
President and CEO, Director
Signature
/s/ Andrew Obenshain
Stock symbol
BLUE
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
4
Date filed
3/3/2023, 03:43 PM
Previous filing
Feb 3, 2023
Next filing
Aug 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLUE Common Stock Award $0 +67.6K +28.02% $0.00 309K Mar 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLUE Stock Option (right to buy) Award $0 +338K $0.00 338K Mar 1, 2023 Common Stock 338K $5.11 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit awards vest over a four-year period at the rate of 25% on 01/03/2024, 25% on 01/03/2025, 25% on 01/03/2026, and 25% on 01/03/2027.
F2 This stock option vests over a four-year period at the rate of 25% on 01/03/2024 and then in 36 equal monthly installments thereafter